Skip to main content
Signal8

Agrawal Sundeep

SEC insider (Form 3/4/5 filer). CIK 0001840599. Director at BlossomHill Therapeutics, Inc. (BLSM) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.

Companies Agrawal Sundeep has filed insider reports for

  • BlossomHill Therapeutics, Inc. (BLSM): Director
  • PAVmed Inc. (PAVM): Director
Agrawal Sundeep profile photo

Agrawal Sundeep

CIK: 0001840599

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BlossomHill Therapeutics, Inc. logo
BLSM

BlossomHill Therapeutics, Inc.

Director
PAVmed Inc. logo
PAVM

PAVmed Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • BlossomHill Therapeutics, Inc. logo
    BLSM

    BlossomHill Therapeutics, Inc.

    Aug 10, 2026
    Conversion
    Indirect
    578.5K shares-
  • BlossomHill Therapeutics, Inc. logo
    BLSM

    BlossomHill Therapeutics, Inc.

    Aug 6, 2026
    Award

    Director Stock Option (Right to Buy)

    Direct
    23.9K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Apr 2, 2026
    Award
    Direct
    13.9K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Sep 30, 2025
    Award
    Direct
    150K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Oct 21, 2024
    Award

    Employee stock option (right to buy)

    Direct
    50K shares-
  • PAVmed Inc. logo
    PAVM

    PAVmed Inc.

    Sep 19, 2024
    Award

    Employee stock option (right to buy)

    Direct
    205K shares-

1-6 of 6